GBS Corp

The GBS Remote Patient Monitoring platform has demonstrated significant clinical impact in real-world settings. Reported outcomes include nearly universal daily self-measurement compliance among patients and substantial reductions in ER visits (by up to 50%), hospitalizations (by up to 30%), and readmissions at both the seven-day and thirty-day marks. The system generates average monthly revenue per patient of $184.25 ($2,211 annually), with high engagement rates observed during hospital system implementations.

Devices are pre-configured for ease of use ("senior simple"), transmit data via cellular networks or WiFi directly into EHRs in real time, and comply with HIPAA/ISO standards. The solution includes AI-driven analytics for early intervention and personalized engagement.

The company reports over twelve million patient interactions across fifteen years of R&D.

Clinical results are based on implementation data from partner hospitals rather than formal clinical trials.

[1][3][5]